News

"We are very pleased that FDA has granted Fast Track designation for EG-1962 for the treatment of SAH," said Brian A. Leuthner, Edge’s Chief Executive Officer. "The FDA

A severe, rare, inherited disorder of the liver, PH1 often results in kidney failure, and there are no approved therapies for the disease. The U.S. Food and Drug

The company enforced a distribution restriction for particular products that have been part of, or considered by various states for their lethal injection protocols. The products include pancuronium

US states and territories can now apply to the Centers for Disease Control and Prevention (CDC) for funds to fight Zika locally. The CDC said $25m in preparedness

Mylan will pay $950m in cash up front and up to $50m in future payments. The deal adds about 25 branded and generic products, a 25-product pipeline and

"We are very pleased to progress to the Phase 2 portion of this trial evaluating FPA008 as a treatment for patients with PVNS, an orphan joint disease associated

"These preliminary agreements in principle with the DOJ and the SEC represent an important step forward towards addressing the immediate issues facing Aegerion and positioning the Company for

The collaboration between HTG and Bristol-Myers Squibb will utilize the next generation sequencing (NGS)-based HTG EdgeSeq system as a tool for use in support of Bristol-Myers Squibb’s translational

In its written response, the FDA advised Tetraphase that data from one additional positive phase 3 clinical trial will be required to support a New Drug Application (NDA)